[Recommendations for the management of diabetic patients with nephropathy].
In industrialized countries diabetic nephropathy is now the most common cause of end-stage renal disease and is associated not only with a high morbidity rate, but also a dramatic increase in mortality. The 5-year survival rate of diabetic patients on hemodialysis is 25-30% and is thus comparable with that of patients with colorectal cancer. The increasing numbers of diabetics on renal replacement therapy also put a great financial strain--on average 40,000-50,000 euros per patient and year--on our health care system. An increased rate of micro- and macrovascular complications is found already in early stages of diabetic nephropathy. Despite the existence of suitable screening methods and effective interventional strategies for these high-risk patients, their practical implementation leaves much to be desired. In particular there is much room for improvement in the cooperation between general practitioners, diabetologists and nephrologists.
Rupprecht
H
H
Leitender Arzt, Medizinische Klinik V, Klinikum Bayreuth GmbH. Harald.Rupprecht@med.uni-muenchen.de
Piehlmeier
W
W
D000419:Albuminuria / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D003299:Cooperative Behavior; D003404:Creatinine / Q000097:blood; D003922:Diabetes Mellitus, Type 1 / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D003924:Diabetes Mellitus, Type 2 / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D003928:Diabetic Nephropathies / Q000175:diagnosis / Q000209:etiology / Q000628:therapy*; D005194:Family Practice; D005858:Germany; D006801:Humans; D007676:Kidney Failure, Chronic / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D007677:Kidney Function Tests; D010348:Patient Care Team; D017582:Renal Replacement Therapy
D003404:Creatinine